Abiopharma

Clinical trial NCT07547436: start date: 2026-06-15 → 2026-06-08.

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Clinical trial NCT06188208 updates: 1. completion date: 2025-12-21 → 2026-02-20 2. primary completion date: 2025-12-21 → 2026-02-20

Clinical trial NCT07577817: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT07527858 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-05-19

Clinical trial NCT05933681 updates: 1. completion date: 2026-05-30 → 2027-05-01 2. primary completion date: 2025-07-30 → 2026-08-01

Clinical trial NCT07160257 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-02-19 → 2027-03-04 3. primary completion date: 2026-11-02 → 2026-11-15 4. enrollment: 57 → 56 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06052631: start date: 2026-06-16 → 2026-06-17.

Clinical trial NCT06439524 updates: 1. completion date: 2026-08-15 → 2028-12-01 2. primary completion date: 2026-02-15 → 2028-06-30

Shake Shack Appoints Christiane Pendarvis to Board of Directors